The 61st annual American Society of Mass Spectrometry conference (ASMS) was held this year at the downtown convention center in Minneapolis, Minnesota. Attendance totaled 6,139, down from 6,277 last year (see IBO 5/31/12). The number of new instrument introductions was clearly lower at this year’s event in contrast to the last several years. However, this […]
Cancer and personalized medicine are two research areas in which discoveries are accelerating. Supporting research in these fields are biobanks for the storage of tissue samples. The presence of all types of biobanks has increased at such a rate that nearly two-thirds of US biobanks have emerged within the past decade. According to the NIH’s […]
US equity markets remained bullish in May despite soft economic growth. First quarter GDP was revised down slightly from 2.5% to 2.4% due to lower inventory investments. However, accommodating monetary policies both domestically and abroad continued to fuel equity prices. The Dow Jones Industrial Average, S&P 500 and NASDAQ climbed 1.9%, 2.1% and 3.8% in […]
The calendar-year first quarter proved challenging for some major publicly held instrument and laboratory product companies. In general, industrial end-markets were soft, US and European academic and government spending remained constrained, and a weaker yen hurt sales and profitability. In addition, Bruker and PerkinElmer experienced unexpected events related to operational issues and weaker-than-expected sales in […]
The Cyto 2013 conference for flow cytometry took place this year in San Diego, California, from May 19–22. Put on by the International Society for Advancement of Cytometry, the conference drew over 1,600 registrants, according to preliminary estimates, compared with 1,521 last year, when the conference was held in Leipzig, Germany. Seventy-two vendors participated in […]
First quarter revenue growth for IBO’s Laboratory Instrument Sales Index slowed to 0.7%, 1.9% excluding currency, to $5,912 million. Operating profit declined 2.9% to $1,215 million, and operating margin fell 80 basis points to 17.9% of sales. Financial estimates are included for Oxford Instruments, Spectris and Tecan, which have yet to report first quarter financial […]
Investors may find solace in the correlation between compensation awards and financial performance at the 37 firms in IBO’s Stock Indexes. In fiscal 2012 (FY12), total compensation packages declined for 28 of the 44 presidents, CEOs or heads of dedicated business units at these companies who have held their respective roles for more than one […]
Instrument and lab product company executives appear more optimistic about sales prospects now than they did in fall 2012, according to the latest results of the IBO Business Climate Survey. This is despite the US budget sequestration and recent downgrade in expectations for world GDP growth by the International Monetary Fund (IMF). In April, the […]
Sustained quantitative easing measures in the US, Japan and China, along with better-than-expected earnings reports and jobless claims toward the end of April, helped elevate the Dow Jones Industrial Average and S&P 500 to new highs this month. However, equity markets came under pressure earlier in the month due to slower manufacturing and durable goods […]
In March, NanoSight began shipping its NS300 nanoparticle characterization system, a smaller and less costly alternative to its NS500. The systems utilize nanoparticle tracking analysis technology based on automated digital microscopy to provide the size distribution and concentration of nanoparticles from 10 nm to 2000 nm in size in liquids. At 23 x 39 cm […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
